Fasika A. Woreta, M.D., M.P.H. is a cornea and cataract specialist and the Eugene de Juan, M.D. Professor of Ophthalmic Education at Wilmer Eye Institute’s Baltimore and Columbia locations. Her expertise is in in corneal and external eye diseases, including complex cataracts and anterior segment reconstruction following trauma. Dr. Woreta is currently the director of the Eye Trauma Center and the director of the Ophthalmology Residency Program at the Wilmer Eye Institute. An associate professor of ophthalmology, Dr. Woreta received her M.D. degree from the Johns Hopkins University School of Medicine and her M.P.H. degree from the Johns Hopkins Bloomberg School of Public Health. She completed her residency in ophthalmology at the Wilmer Eye Institute, then completed a fellowship in cornea and refractive surgery at the Bascom-Palmer Eye Institute at the University of Miami, as well as an accident and emergency and cataract fellowship at Moorfields Eye Hospital. Dr. Woreta is highly rated in 13 conditions, according to our data. Her top areas of expertise are Endophthalmitis, Cataract, Hyphema, Cataract Removal, and Corneal Transplant.

Dr. Couser obtained his bachelor’s degree from the University of Virginia and his Medical Doctorate from the Virginia Commonwealth University School of Medicine (VCU SOM). Dr. Couser’s ophthalmology residency was completed at Howard University where he served as co-chief resident in the last year of his residency. He received fellowship training in pediatric ophthalmology and adult strabismus at Emory University. Dr. Couser received a master’s degree in biotechnology from the Johns Hopkins University and completed a residency in clinical genetics at the University of North Carolina at Chapel Hill. He is one of only a few individuals currently board-certified by both the American Board of Ophthalmology and the American Board of Medical Genetics and Genomics. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/couser-cv Research Summary My primary research focus involves the identification and management of genetic eye diseases including rare inherited disorders affecting the eyes. Research and scholarly activities have been an integral component of my career path. I have been the principal investigator on 10 clinical trial/IRB studies and a co-investigator on others, participated with several committees or advisory panels related to research activities. I have been credited with over 120 book chapter, journal article and abstract publications. In addition, I served as the primary author/sole editor for a textbook titled Ophthalmic Genetic Diseases: A Quick Reference Guide to the Eye and External Ocular Adnexa Abnormalities, 1st Edition, published by Elsevier in 2018, which is one of only a few textbooks published in this subject area. I also served as a grant review panelist for the National Eye Institute Career Development Awards. Selected Publications *Couser NL, Masood MM, Strande NT, Foreman AKM, Crooks K, Weck KE, Lu M, Wilhelmsen KC, Roche M, Evans JP, Berg JS, Powell CM. 2015. The phenotype of multiple congenital anomalies- hypotonia-seizures syndrome 1: Report and review. Am J Med Genet Part A 9999A:1–6 *Couser NL, Lambert SR. Botulinum toxin: A treatment of consecutive esotropia in children. Strabismus 2012; 20(4):158-161 Couser NL, Lenhart PD, Hutchinson AK. Augmented Hummelsheim procedure to treat complete abducens nerve palsy. J AAPOS 2012;16(4):331-5 *Natario L. Couser, Maheer M. Masood, Arthur S. Aylsworth, and Roger E. Stevenson. Ocular manifestations in the X-linked intellectual disability syndromes. Ophthalmic Genet. 2017, Jan 23:1-12 *Couser NL, Brooks BP, Drack AV, Shankar SP. The evolving role of genetics in ophthalmology. Ophthalmic Genet. 2021 Jan 12:1-4. doi: 10.1080/13816810.2020.1868011. Dr. Couser is highly rated in 13 conditions, according to our data. His top areas of expertise are Epicanthal Folds, Strabismus, Brown Syndrome, and Hypotonia.

Anshu Sinha is an Ophthalmologist in Columbia, Maryland. Dr. Sinha is highly rated in 6 conditions, according to our data. Her top areas of expertise are Glaucoma, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Ocular Hypertension (OHT).

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is highly rated in 18 conditions, according to our data. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is highly rated in 18 conditions, according to our data. His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

T. Y. Alvin Liu, M.D. is the James P. Gills, Jr. M.D., and Heather Gills Rising Professor of AI and the founding director of the Wilmer Precision Ophthalmology Center of Excellence. He is originally from Hong Kong, and speaks fluent Cantonese and Mandarin. He attended Phillips Exeter Academy in Exeter, New Hampshire, and graduated from Cornell University with a dual major in biology and economics. He received his M.D. from Columbia University in 2012, and completed his residency (2016) and fellowship (surgical and medical retina- 2018) at Johns Hopkins. He is subspecialty-trained in the medical and surgical treatment of vitreoretinal diseases, including age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane and macular hole. Dr. Liu's research interests center on the application of artificial intelligence in the screening, diagnosis, prognostication and treatment of ophthalmic diseases, with a specific focus on vitreoretinal diseases such as age-related macular degeneration and diabetic retinopathy. In addition, he is involved in research on the pathogenesis of and treatment for pathologic myopia and the management of severe ocular trauma. Videos Dr. Tin Yan Alvin Liu Recent News Articles and Media Coverage AI Speeds Diabetic Retinopathy Diagnosis Without Specialist. Medscape August 28, 2018 AI Screening for Diabetic Retinopathy Moves to Retail Clinics. Medscape November 26, 2019 How Artificial Intelligence is Primed to Change Ophthalmology. Ophthalmology Advisor May 14, 2021 Medicine's first autonomous AI could prevent blindness due to diabetes. Stat News December 16, 2021 Innovations in Eye Care: How Technology is Transforming Ophthalmology. HealthTech November 29, 2022 Time to go multicultural. Retina Today March 1, 2023 How deep learning may play a role in predicting retinitis pigmentosa visual impairment. Ophthalmology Times March 14, 2023 AI in retinal diagnostics. Zhaoke Ophthalmology March 22, 2023 Macular Degeneration. Spotlight on Geographic Atrophy. Advances in Treatment. WebMD April 23, 2023 ARVO 2023: T.Y. Alvin Liu, MD discusses predictive AI and its application in ophthalmology. Modern Retina April 25, 2023 ASCRS: Prediction of imminent conversion to neovascular AMD using deep learning and 3D OCT volumes. OptometryTimes May 5, 2023 Adopting and regulating AI in healthcare. BNN Bloomberg May 29, 2023 AI could increase health equity and boost adherence to annual eye examination in patients with diabetes. Modern Retina June 21, 2023 As more Marylanders grow older, a debilitating eye disease is gaining ground. The Baltimore Banner June 26, 2023. Dr. Liu is highly rated in 14 conditions, according to our data. His top areas of expertise are Usher Syndrome Type 2A, Cone Rod Dystrophy Amelogenesis Imperfecta, Cone-Rod Dystrophy, and Stargardt Macular Degeneration.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is highly rated in 14 conditions, according to our data. Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

Douglas A. Jabs, M.D., M.B.A. is an internationally-recognized expert in the evaluation and management of patients with uveitis and related immune-mediated ocular disorders, particularly on the use of immunosuppression to treat severe ocular inflammatory diseases. Founder of the Division of Ocular Immunology and Uveitis at Wilmer, he now is the Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins University Bloomberg School of Public Health. Dr. Jabs is highly rated in 13 conditions, according to our data. His top areas of expertise are Uveitis, CMV Retinitis, Scleritis, Cataract Removal, and Trabeculectomy.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is highly rated in 10 conditions, according to our data. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.

Divya Srikumaran, M.D., is the Walter J. Stark Chair of Ophthalmology at the Wilmer Eye Institute, and practices at Wilmer's East Baltimore and Odenton, Maryland locations. She specializes in diagnosing and treating diseases of the cornea, performing corneal transplants, cataract surgeries, and refractive surgeries (LASIK). She is an investigator for several clinical trials at Wilmer offering her patients the latest treatment options. She has published numerous articles in peer-reviewed journals and lectures at national cornea and cataract conferences. Dr. Srikumaran, an associate professor of ophthalmology in the Division of Cornea and External Disease at the Johns Hopkins Wilmer Eye Institute received her M.D. degree from Northwestern University Feinberg School of Medicine, after which she completed her ophthalmology residency and cornea fellowship training at the Wilmer Eye Institute. Dr. Srikumaran’s research interest includes the assessment of corneal transplant outcomes and risk factors for receiving keratoplasty through big data sources including administrative claims data. She received the Hoskins Center IRIS Registry Research Fund Award through the American Academy of Ophthalmology as well as the EBAA Pilot Research grant to study real-world endothelial keratoplasty outcomes. She is a busy clinician who is actively involved in multi-central clinical trials in cornea. In addition, she serves on the scientific program committee of the EBAA and is participating in their Physician Leadership Program. She is also a member of the editorial board for Cornea and will serve as an associate editor for the society’s new journal Cornea Open. She is also a renowned educator and currently serves as Vice Chair of Education and was previously residency program director. As vice chair of education, she has an interest in medical education and studying best practices to support doctors in training and has been awarded several teaching awards. Blending her passion for both education and expertise in corneal surgery, Dr. Srikumaran has also studied barriers to adoption of advanced keratoplasty procedures in the US and abroad. Dr. Srikumaran is also an examiner and member of the cornea and cataract exam content development committees for the American Board of Ophthalmology and was selected to participate in their Visiting Scholar Program. Dr. Srikumaran is highly rated in 9 conditions, according to our data. Her top areas of expertise are Cataract, Fuchs Dystrophy, Endophthalmitis, Corneal Transplant, and Cataract Removal.

Bryn M. Burkholder, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute and the Antoinette R. Schifanelli Rising Professor of Ophthalmology, specializing in ocular inflammatory and infectious diseases, cataract surgery and comprehensive ophthalmology. Dr. Burkholder earned her bachelor's degree from Duke University, where she majored in biology, and received her medical degree from the University of Pennsylvania. After completing an internship at the Albert Einstein Medical Center in Philadelphia, she moved to Baltimore for her residency in ophthalmology at the Wilmer Eye Institute. Dr. Burkholder remained at Wilmer for her fellowship training in uveitis before joining the faculty in July 2012. Dr. Burkholder is highly rated in 9 conditions, according to our data. Her top areas of expertise are Uveitis, Scleritis, Neuroretinitis, Episcleritis, and Cataract Removal.

Allen O. Eghrari, M.D., M.P.H., is director of the Dana Center for Preventive Ophthalmology at the Wilmer Eye Institute and associate professor of ophthalmology at the Johns Hopkins University School of Medicine. He specializes in cornea, cataract and external eye diseases at the Wilmer Eye Institute's locations in Baltimore and Belcamp, Maryland. Dr. Eghrari treats a wide range of eye conditions, with special interest in Fuchs' dystrophy, cataract surgery, cornea transplantation including Descemet Membrane Endothelial Keratoplasty, and Ebola-associated eye disease. Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute. Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. Dr. Eghrari is highly rated in 7 conditions, according to our data. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.

David L. Guyton, M.D., is the Zanvyl Krieger Professor of Ophthalmology. He is internationally known for his contributions, inventions, and teaching in the fields of ophthalmic optics, clinical refraction, potential acuity testing, and ocular motility. His clinical practice in strabismus is heavily surgical, both pediatric and adult, with emphasis on re-operations and cyclovertical surgery, using adjustable sutures. With adults comprising more than 80 percent of his strabismus surgical cases, Dr. Guyton has contributed significantly to our knowledge of strabismus complications from local anesthetics, the “inverted Brown pattern,” the “dragged-fovea diplopia syndrome,” theories of how and why strabismus develops in the first place, and how and why it can change over time. Dr. Guyton is currently developing automated instruments for the vision screening of infants and children. Dr. Guyton is highly rated in 5 conditions, according to our data. His top areas of expertise are Strabismus, Brown Syndrome, Amblyopia, and Esotropia.

Dean S. Glaros, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a comprehensive ophthalmologist with special interests in cataract surgery, glaucoma, diabetes, dry eye and other medical eye conditions. He also performs routine eye exams for patients age 6 and older. Dr. Glaros received his medical degree from the University of Maryland and performed his medical internship at the University of North Carolina Affiliate Program. He completed his residency in ophthalmology at the University of Maryland. Before joining the Wilmer faculty, he was in private practice in the Baltimore area. Dr. Glaros is a member of the American Academy of Ophthalmology. Dr. Glaros is highly rated in 4 conditions, according to our data. His top areas of expertise are Cataract, X-Linked Retinal Dysplasia, X-Linked Juvenile Retinoschisis, and Glaucoma.

Dr. Sherry Narang Kalla is an assistant professor of ophthalmology at the Johns Hopkins School of Medicine. Her areas of clinical expertise includes comprehensive ophthalmology. Dr. Narang Kalla received her undergraduate degree from Gannon University, where she was a Hamlot Scholar. In 2005, she earned her medical degree from Drexel University College of Medicine. She completed a pediatric residency at Children’s National Medical Center in 2009, and her ophthalmology residency at SUNY Downstate Medical Center in 2013, where she served as chief administrative resident. Prior to joining Johns Hopkins, Dr. Narang Kalla served as an Assistant Clinical Professor of Pediatrics and an ER Clinical Associate at Children’s National Medical Center. She has been in private practice since 2013, at Patapsco Eye MDs, in Columbia, Maryland. Dr. Narang Kalla is a member of the American Academy of Ophthalmology, the American Academy of Pediatrics, and the American Association of Physicians of Indian Origin. Dr. Kalla is highly rated in 3 conditions, according to our data. Her top areas of expertise are Cataract, Glaucoma, Dry Eye Syndrome, and Blepharitis.

Olga Shif is an Ophthalmologist in Elkridge, Maryland. Dr. Shif is highly rated in 21 conditions, according to our data. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy, and Vitrectomy. Dr. Shif is currently accepting new patients.

Alan Malouf is an Ophthalmologist in Columbia, Maryland. Dr. Malouf is highly rated in 19 conditions, according to our data. His top areas of expertise are Dry Eye Syndrome, Cataract, Glaucoma, and Allergic Conjunctivitis. Dr. Malouf is currently accepting new patients.

Jonathan Etter is an Ophthalmologist in Columbia, Maryland. Dr. Etter is highly rated in 14 conditions, according to our data. His top areas of expertise are Interstitial Keratitis, Cataract, Blepharitis, and Sjogren Syndrome. Dr. Etter is currently accepting new patients.

Parvathy Pillai is an Ophthalmologist in Columbia, Maryland. Dr. Pillai is highly rated in 9 conditions, according to our data. Her top areas of expertise are Cataract, Neuroretinitis, Glaucoma, and Uveitis. Dr. Pillai is currently accepting new patients.

Scott Becker is an Ophthalmologist in Columbia, Maryland. Dr. Becker is highly rated in 7 conditions, according to our data. His top areas of expertise are Blepharitis, Sjogren Syndrome, Interstitial Keratitis, and Cataract. Dr. Becker is currently accepting new patients.

Scott Laborwit is an Ophthalmologist in Elkridge, Maryland. Dr. Laborwit is highly rated in 7 conditions, according to our data. His top areas of expertise are Cataract, Presbyopia, Astigmatism, Glaucoma, and Cataract Removal.

Lenard Hammer is an Ophthalmologist in Columbia, Maryland. Dr. Hammer is highly rated in 6 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Glaucoma, and Geographic Atrophy. Dr. Hammer is currently accepting new patients.

Ruth Tessema, M.D., is an ophthalmologist at the Wilmer Eye Institute, Johns Hopkins Medicine Howard County and Frederick locations. She earned her medical degree from Howard University and completed her ophthalmology residency at the UC Davis Eye Center. Before joining the Wilmer Eye Institute, she worked as an ophthalmologist with Kaiser Permanente in California. A lifelong interest in science and a passion for helping people live healthy, full lives led Dr. Tessema into medicine and the field of ophthalmology. She approaches care with the recognition that eyesight is vital to patient well-being and independence, and she strives to be a patient advocate, to remove systemic barriers to quality care and to protect the health and dignity of everyone she works with. Dr. Tessema has clinical experience in cataract surgery, glaucoma management, diabetic eye disease, dry eye treatment, and eyelid and ocular surface disorders. Her top area of expertise is Uveitis.

Fernando Arevalo is an Ophthalmologist in Baltimore, Maryland. Dr. Arevalo is highly rated in 11 conditions, according to our data. His top areas of expertise are Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.

Cindy X. Cai, M.D., is the Jonathan and Marcia Javitt Rising Professor of Ophthalmology and a retina specialist seeing patients at the Wilmer Eye Institute’s locations in the Baltimore, Maryland area. Her primary focuses are in medical and surgical retina treatments, including: diabetic retinopathy, diabetic macular edema, age-related macular degeneration, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane, and macular hole, among others. Dr. Cai graduated summa cum laude with a major in biology at Columbia University and received her M.D. from the Columbia University College of Physicians and Surgeons in New York. She completed her medical internship at Mercy Medical Center in Baltimore and her ophthalmology residency training at the Wilmer Eye Institute. She received her vitreoretinal surgery fellowship training at Duke Eye Center. Videos Dr. Cindy X. CaiOphthalmologist and Retina Specialist Recent News Articles and Media Coverage Continuing the Mission, Johns Hopkins Medicine (Dec. 2021) Get to Know Cindy Cai, Wilmer Insider (Apr. 2021). Dr. Cai is highly rated in 9 conditions, according to our data. Her top areas of expertise are Diabetic Retinopathy, Diabetic Macular Edema (DME), Gyrate Atrophy of the Choroid and Retina, Vitrectomy, and Cataract Removal.